View in EDS

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

Saved in:
Bibliographic Details
Title: Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
Authors: Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Electronic address: dwells@parkerici.org., van Buuren MM; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; T Cell Immunology, Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech US, Cambridge, MA, USA., Dang KK; Computational Oncology, Sage Bionetworks, Seattle, WA, USA., Hubbard-Lucey VM; Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA., Sheehan KCF; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO, USA; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA., Campbell KM; Division of Hematology and Oncology, Department of Medicine, Johnson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Lamb A; Computational Oncology, Sage Bionetworks, Seattle, WA, USA., Ward JP; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Sidney J; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA., Blazquez AB; Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rech AJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Zaretsky JM; Division of Hematology and Oncology, Department of Medicine, Johnson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Comin-Anduix B; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Surgery, David Geffen School of Medicine, Johnson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Ng AHC; Institute for Systems Biology, Seattle, WA, USA., Chour W; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA., Yu TV; Computational Oncology, Sage Bionetworks, Seattle, WA, USA., Rizvi H; Druckenmiller Center for Lung Cancer Research, MSKCC, New York, NY, USA., Chen JM; Division of Hematology and Oncology, Department of Medicine, Johnson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Manning P; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Steiner GM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Doan XC; Computational Oncology, Sage Bionetworks, Seattle, WA, USA., Merghoub T; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Medicine, MSKCC, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Guinney J; Computational Oncology, Sage Bionetworks, Seattle, WA, USA; Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA., Kolom A; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA., Selinsky C; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Ribas A; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, Johnson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Hellmann MD; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Druckenmiller Center for Lung Cancer Research, MSKCC, New York, NY, USA; Department of Medicine, MSKCC, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Hacohen N; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sette A; Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, University of California, San Diego, La Jolla, CA, USA., Heath JR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Institute for Systems Biology, Seattle, WA, USA., Bhardwaj N; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ramsdell F; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Schreiber RD; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO, USA; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA., Schumacher TN; Division of Molecular Oncology and Immunology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Kvistborg P; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Defranoux NA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Electronic address: ndefranoux@parkerici.org.
Corporate Authors: Tumor Neoantigen Selection Alliance
Source: Cell [Cell] 2020 Oct 29; Vol. 183 (3), pp. 818-834.e13. Date of Electronic Publication: 2020 Oct 09.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33038342
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wells+DK%22">Wells DK</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Electronic address: dwells@parkerici.org.<br /><searchLink fieldCode="AU" term="%22van+Buuren+MM%22">van Buuren MM</searchLink>; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; T Cell Immunology, Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech US, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dang+KK%22">Dang KK</searchLink>; Computational Oncology, Sage Bionetworks, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Hubbard-Lucey+VM%22">Hubbard-Lucey VM</searchLink>; Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sheehan+KCF%22">Sheehan KCF</searchLink>; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO, USA; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Campbell+KM%22">Campbell KM</searchLink>; Division of Hematology and Oncology, Department of Medicine, Johnson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lamb+A%22">Lamb A</searchLink>; Computational Oncology, Sage Bionetworks, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Ward+JP%22">Ward JP</searchLink>; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Sidney+J%22">Sidney J</searchLink>; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Blazquez+AB%22">Blazquez AB</searchLink>; Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rech+AJ%22">Rech AJ</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zaretsky+JM%22">Zaretsky JM</searchLink>; Division of Hematology and Oncology, Department of Medicine, Johnson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Comin-Anduix+B%22">Comin-Anduix B</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Surgery, David Geffen School of Medicine, Johnson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ng+AHC%22">Ng AHC</searchLink>; Institute for Systems Biology, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Chour+W%22">Chour W</searchLink>; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yu+TV%22">Yu TV</searchLink>; Computational Oncology, Sage Bionetworks, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Rizvi+H%22">Rizvi H</searchLink>; Druckenmiller Center for Lung Cancer Research, MSKCC, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chen+JM%22">Chen JM</searchLink>; Division of Hematology and Oncology, Department of Medicine, Johnson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Manning+P%22">Manning P</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Steiner+GM%22">Steiner GM</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Doan+XC%22">Doan XC</searchLink>; Computational Oncology, Sage Bionetworks, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Merghoub+T%22">Merghoub T</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Medicine, MSKCC, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Guinney+J%22">Guinney J</searchLink>; Computational Oncology, Sage Bionetworks, Seattle, WA, USA; Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Kolom+A%22">Kolom A</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Selinsky+C%22">Selinsky C</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ribas+A%22">Ribas A</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, Johnson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Hellmann+MD%22">Hellmann MD</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Druckenmiller Center for Lung Cancer Research, MSKCC, New York, NY, USA; Department of Medicine, MSKCC, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hacohen+N%22">Hacohen N</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sette+A%22">Sette A</searchLink>; Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Heath+JR%22">Heath JR</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Institute for Systems Biology, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Bhardwaj+N%22">Bhardwaj N</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ramsdell+F%22">Ramsdell F</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schreiber+RD%22">Schreiber RD</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO, USA; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Schumacher+TN%22">Schumacher TN</searchLink>; Division of Molecular Oncology and Immunology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kvistborg+P%22">Kvistborg P</searchLink>; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Defranoux+NA%22">Defranoux NA</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Electronic address: ndefranoux@parkerici.org.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Tumor+Neoantigen+Selection+Alliance%22">Tumor Neoantigen Selection Alliance</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413066%22">Cell</searchLink> [Cell] 2020 Oct 29; Vol. 183 (3), pp. 818-834.e13. <i>Date of Electronic Publication: </i>2020 Oct 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413066 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-4172 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200928674%22">00928674 </searchLink><i>NLM ISO Abbreviation: </i>Cell <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33038342
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cell.2020.09.015
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 818
    Titles:
      – TitleFull: Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wells DK
      – PersonEntity:
          Name:
            NameFull: van Buuren MM
      – PersonEntity:
          Name:
            NameFull: Dang KK
      – PersonEntity:
          Name:
            NameFull: Hubbard-Lucey VM
      – PersonEntity:
          Name:
            NameFull: Sheehan KCF
      – PersonEntity:
          Name:
            NameFull: Campbell KM
      – PersonEntity:
          Name:
            NameFull: Lamb A
      – PersonEntity:
          Name:
            NameFull: Ward JP
      – PersonEntity:
          Name:
            NameFull: Sidney J
      – PersonEntity:
          Name:
            NameFull: Blazquez AB
      – PersonEntity:
          Name:
            NameFull: Rech AJ
      – PersonEntity:
          Name:
            NameFull: Zaretsky JM
      – PersonEntity:
          Name:
            NameFull: Comin-Anduix B
      – PersonEntity:
          Name:
            NameFull: Ng AHC
      – PersonEntity:
          Name:
            NameFull: Chour W
      – PersonEntity:
          Name:
            NameFull: Yu TV
      – PersonEntity:
          Name:
            NameFull: Rizvi H
      – PersonEntity:
          Name:
            NameFull: Chen JM
      – PersonEntity:
          Name:
            NameFull: Manning P
      – PersonEntity:
          Name:
            NameFull: Steiner GM
      – PersonEntity:
          Name:
            NameFull: Doan XC
      – PersonEntity:
          Name:
            NameFull: Merghoub T
      – PersonEntity:
          Name:
            NameFull: Guinney J
      – PersonEntity:
          Name:
            NameFull: Kolom A
      – PersonEntity:
          Name:
            NameFull: Selinsky C
      – PersonEntity:
          Name:
            NameFull: Ribas A
      – PersonEntity:
          Name:
            NameFull: Hellmann MD
      – PersonEntity:
          Name:
            NameFull: Hacohen N
      – PersonEntity:
          Name:
            NameFull: Sette A
      – PersonEntity:
          Name:
            NameFull: Heath JR
      – PersonEntity:
          Name:
            NameFull: Bhardwaj N
      – PersonEntity:
          Name:
            NameFull: Ramsdell F
      – PersonEntity:
          Name:
            NameFull: Schreiber RD
      – PersonEntity:
          Name:
            NameFull: Schumacher TN
      – PersonEntity:
          Name:
            NameFull: Kvistborg P
      – PersonEntity:
          Name:
            NameFull: Defranoux NA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 10
              Text: 2020 Oct 29
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1097-4172
          Numbering:
            – Type: volume
              Value: 183
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Cell
              Type: main
ResultId 1